# Intraarterial Alteplase Versus Placebo After Mechanical Thrombectomy

Study · id `cardio:ct-nct03876119` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03876119](<https://clinicaltrials.gov/study/NCT03876119>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03876119

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.

## Technical summary

Registry record NCT03876119. Randomized; quadruple masking; primary purpose treatment. Start 2018-12-05 (actual); primary completion 2021-05-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 121 participants (enrolled count; ClinicalTrials.gov record NCT03876119, source copy `cardio:ctgov-nct03876119-2022-05-20`, retrieved 2026-10-26)
- Started: 2018-12-05 (actual) (ClinicalTrials.gov record NCT03876119, source copy `cardio:ctgov-nct03876119-2022-05-20`, retrieved 2026-10-26)
- Primary completion: 2021-05-31 (actual) (ClinicalTrials.gov record NCT03876119, source copy `cardio:ctgov-nct03876119-2022-05-20`, retrieved 2026-10-26)
- Completion: 2021-05-31 (actual) (ClinicalTrials.gov record NCT03876119, source copy `cardio:ctgov-nct03876119-2022-05-20`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT03876119, source copy `cardio:ctgov-nct03876119-2022-05-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03876119-2022-05-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intraarterial Alteplase Versus Placebo After Mechanical Thrombectomy
- Acronym: CHOICE
- Condition: Stroke, Acute
- Intervention (Drug): Intraarterial alteplase
- Intervention (Drug): Placebo
- Lead sponsor: Hospital Clinic of Barcelona
- Lead sponsor class: OTHER
- Collaborator: Fundació La Marató de TV3
- Collaborator class: OTHER
- Collaborator: Fundacion Clinic per a la Recerca Biomédica
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Hospital Clinic of Barcelona (`cardio:org-hospital-clinic-of-barcelona`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke: The CHOICE Randomized Clinical Trial (`cardio:pubmed-35143603`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b8e28ed18effdca53bda9d00f7014cd9b0c3ab9bc0180547d6e2784614df4562
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
